80bn — latest news 05:0120 JulAstraZeneca highlights rare diseases in $80bn revenue push(Financial Times) Popular topics #cryptocurrency #space #finance #personal #league #games #premier #review #manchester #wimbledon #financial #england #pros #cons #british #diaries #medicine #timelines #stylist #trashed